{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T05:21:49Z","timestamp":1775539309438,"version":"3.50.1"},"reference-count":95,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2014,5,10]],"date-time":"2014-05-10T00:00:00Z","timestamp":1399680000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroimmune Pharmacol"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1007\/s11481-014-9546-0","type":"journal-article","created":{"date-parts":[[2014,5,9]],"date-time":"2014-05-09T00:38:18Z","timestamp":1399595898000},"page":"483-491","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":69,"title":["Role of HIV in Amyloid Metabolism"],"prefix":"10.1007","volume":"9","author":[{"given":"Mario","family":"Ortega","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beau M.","family":"Ances","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,5,10]]},"reference":[{"key":"9546_CR1","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s11481-009-9152-8","volume":"4","author":"CL Achim","year":"2009","unstructured":"Achim CL, Adame A, Dumaop W et al (2009) Increased accumulation of intraneuronal amyloid beta in HIV-infected patients. J Neuroimmune Pharmacol 4:190\u20139. doi: 10.1007\/s11481-009-9152-8","journal-title":"J Neuroimmune Pharmacol"},{"key":"9546_CR2","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/alzrt2","volume":"1","author":"PS Aisen","year":"2009","unstructured":"Aisen PS (2009) Alzheimer\u2019s disease therapeutic research: the path forward. Alzheimer\u2019s Res Ther 1:2. doi: 10.1186\/alzrt2","journal-title":"Alzheimer\u2019s Res Ther"},{"key":"9546_CR3","author":"C Akay","year":"2014","unstructured":"Akay C, Cooper M, Odeleye A et al (2014) Antiretroviral drugs induce oxidative stress and neuronal damage in the central nervous system. J Neurovirol. doi: 10.1007\/s13365-013-0227-1","journal-title":"J Neurovirol"},{"key":"9546_CR4","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.neulet.2010.03.073","volume":"475","author":"MY Aksenov","year":"2010","unstructured":"Aksenov MY, Aksenova MV, Mactutus CF, Booze RM (2010) HIV-1 protein-mediated amyloidogenesis in rat hippocampal cell cultures. Neurosci Lett 475:174\u20138. doi: 10.1016\/j.neulet.2010.03.073","journal-title":"Neurosci Lett"},{"key":"9546_CR5","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1097\/00005072-199711000-00011","volume":"56","author":"SF An","year":"1997","unstructured":"An SF, Giometto B, Groves M et al (1997) Axonal damage revealed by accumulation of beta-APP in HIV-positive individuals without AIDS. J Neuropathol Exp Neurol 56:1262\u20138","journal-title":"J Neuropathol Exp Neurol"},{"key":"9546_CR6","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1001\/archneurol.2011.761","volume":"69","author":"BM Ances","year":"2012","unstructured":"Ances BM, Benzinger TL, Christensen JJ et al (2012) 11C-PiB imaging of human immunodeficiency virus-associated neurocognitive disorder. Arch Neurol 69:72\u20137. doi: 10.1001\/archneurol.2011.761","journal-title":"Arch Neurol"},{"key":"9546_CR7","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1212\/WNL.0b013e3181e7b66e","volume":"75","author":"BM Ances","year":"2010","unstructured":"Ances BM, Christensen JJ, Teshome M et al (2010) Cognitively unimpaired HIV-positive subjects do not have increased 11C-PiB: a case\u2013control study. Neurology 75:111\u20135. doi: 10.1212\/WNL.0b013e3181e7b66e","journal-title":"Neurology"},{"key":"9546_CR8","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/iub.1106","volume":"65","author":"IE Andr\u00e1s","year":"2013","unstructured":"Andr\u00e1s IE, Toborek M (2013) Amyloid beta accumulation in HIV-1-infected brain: The role of the blood brain barrier. IUBMB Life 65:43\u20139. doi: 10.1002\/iub.1106","journal-title":"IUBMB Life"},{"key":"9546_CR9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1559-0275-9-3","volume":"9","author":"TE Angel","year":"2012","unstructured":"Angel TE, Jacobs JM, Spudich SS et al (2012) The cerebrospinal fluid proteome in HIV infection: change associated with disease severity. Clin Proteomics 9:3. doi: 10.1186\/1559-0275-9-3","journal-title":"Clin Proteomics"},{"key":"9546_CR10","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/09540260701862037","volume":"20","author":"IC Anthony","year":"2008","unstructured":"Anthony IC, Bell JE (2008) The Neuropathology of HIV\/AIDS. Int Rev Psychiatry 20:15\u201324. doi: 10.1080\/09540260701862037","journal-title":"Int Rev Psychiatry"},{"key":"9546_CR11","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1093\/brain\/awq263","volume":"133","author":"IC Anthony","year":"2010","unstructured":"Anthony IC, Norrby KE, Dingwall T et al (2010) Predisposition to accelerated Alzheimer-related changes in the brains of human immunodeficiency virus negative opiate abusers. Brain 133:3685\u201398. doi: 10.1093\/brain\/awq263","journal-title":"Brain"},{"key":"9546_CR12","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s00401-006-0037-0","volume":"111","author":"IC Anthony","year":"2006","unstructured":"Anthony IC, Ramage SN, Carnie FW et al (2006) Accelerated Tau deposition in the brains of individuals infected with human immunodeficiency virus-1 before and after the advent of highly active anti-retroviral therapy. Acta Neuropathol 111:529\u201338. doi: 10.1007\/s00401-006-0037-0","journal-title":"Acta Neuropathol"},{"key":"9546_CR13","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1212\/01.wnl.0000256043.50901.e3","volume":"68","author":"RJ Bateman","year":"2007","unstructured":"Bateman RJ, Wen G, Morris JC, Holtzman DM (2007) Fluctuations of CSF amyloid-beta levels: implications for a diagnostic and therapeutic biomarker. Neurology 68:666\u20139. doi: 10.1212\/01.wnl.0000256043.50901.e3","journal-title":"Neurology"},{"key":"9546_CR14","doi-asserted-by":"crossref","unstructured":"Bateman RJ, Xiong C, Benzinger TLS, et al. (2012) Clinical and Biomarker Changes in Dominantly Inherited Alzheimer\u2019s Disease. N Engl J Med 120711140017009. doi: 10.1056\/NEJMoa1202753","DOI":"10.1056\/NEJMoa1202753"},{"key":"9546_CR15","doi-asserted-by":"crossref","first-page":"E4502","DOI":"10.1073\/pnas.1317918110","volume":"110","author":"TLS Benzinger","year":"2013","unstructured":"Benzinger TLS, Blazey T, Jack CR et al (2013) Regional variability of imaging biomarkers in autosomal dominant Alzheimer\u2019s disease. Proc Natl Acad Sci U S A 110:E4502\u20139. doi: 10.1073\/pnas.1317918110","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9546_CR16","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrneurol.2010.4","volume":"6","author":"K Blennow","year":"2010","unstructured":"Blennow K, Hampel H, Weiner M, Zetterberg H (2010) Cerebrospinal fluid and plasma biomarkers in Alzheimer disease. Nat Rev Neurol 6:131\u201344. doi: 10.1038\/nrneurol.2010.4","journal-title":"Nat Rev Neurol"},{"key":"9546_CR17","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00702-011-0731-5","volume":"119","author":"N Braidy","year":"2012","unstructured":"Braidy N, Mu\u00f1oz P, Palacios AG et al (2012) Recent rodent models for Alzheimer\u2019s disease: clinical implications and basic research. J Neural Transm 119:173\u201395. doi: 10.1007\/s00702-011-0731-5","journal-title":"J Neural Transm"},{"key":"9546_CR18","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1212\/01.wnl.0000183293.95787.b7","volume":"65","author":"BJ Brew","year":"2005","unstructured":"Brew BJ, Pemberton L, Blennow K et al (2005) CSF amyloid beta42 and tau levels correlate with AIDS dementia complex. Neurology 65:1490\u20132. doi: 10.1212\/01.wnl.0000183293.95787.b7","journal-title":"Neurology"},{"key":"9546_CR19","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1001\/archneurol.2009.279","volume":"66","author":"NJ Cairns","year":"2009","unstructured":"Cairns NJ, Ikonomovic MD, Benzinger T et al (2009) Absence of Pittsburgh compound B detection of cerebral amyloid beta in a patient with clinical, cognitive, and cerebrospinal fluid markers of Alzheimer disease: a case report. Arch Neurol 66:1557\u201362. doi: 10.1001\/archneurol.2009.279","journal-title":"Arch Neurol"},{"key":"9546_CR20","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1471-4159.2011.07584.x","volume":"120","author":"S Chasseigneaux","year":"2012","unstructured":"Chasseigneaux S, Allinquant B (2012) Functions of A\u03b2, sAPP\u03b1 and sAPP\u03b2\u202f: similarities and differences. J Neurochem 120:99\u2013108. doi: 10.1111\/j.1471-4159.2011.07584.x","journal-title":"J Neurochem"},{"key":"9546_CR21","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1016\/j.neurobiolaging.2013.04.015","volume":"34","author":"X Chen","year":"2013","unstructured":"Chen X, Hui L, Geiger NH et al (2013) Endolysosome involvement in HIV-1 transactivator protein-induced neuronal amyloid beta production. Neurobiol Aging 34:2370\u20138. doi: 10.1016\/j.neurobiolaging.2013.04.015","journal-title":"Neurobiol Aging"},{"key":"9546_CR22","doi-asserted-by":"crossref","first-page":"813","DOI":"10.3233\/JAD-121927","volume":"35","author":"H Cho","year":"2013","unstructured":"Cho H, Seo SW, Kim J-H et al (2013) Amyloid deposition in early onset versus late onset Alzheimer\u2019s disease. J Alzheimers Dis 35:813\u201321. doi: 10.3233\/JAD-121927","journal-title":"J Alzheimers Dis"},{"key":"9546_CR23","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S1473-3099(13)70269-X","volume":"13","author":"DB Clifford","year":"2013","unstructured":"Clifford DB, Ances BM (2013) HIV-associated neurocognitive disorder. Lancet Infect Dis 13:976\u201386. doi: 10.1016\/S1473-3099(13)70269-X","journal-title":"Lancet Infect Dis"},{"key":"9546_CR24","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1212\/WNL.0b013e3181c5b445","volume":"73","author":"DB Clifford","year":"2009","unstructured":"Clifford DB, Fagan AM, Holtzman DM (2009) CSF biomarkers of Alzheimer disease in HIV-associated neurologic disease. Neurology 73:1982\u20137. doi: 10.1212\/WNL.0b013e3181c5b445","journal-title":"Neurology"},{"key":"9546_CR25","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/B978-0-12-394816-8.00002-7","volume":"64","author":"AD Cohen","year":"2012","unstructured":"Cohen AD, Rabinovici GD, Mathis CA et al (2012) Using Pittsburgh Compound B for in vivo PET imaging of fibrillar amyloid-beta. Adv Pharmacol 64:27\u201381. doi: 10.1016\/B978-0-12-394816-8.00002-7","journal-title":"Adv Pharmacol"},{"key":"9546_CR26","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.3390\/ijms10031045","volume":"10","author":"L Crews","year":"2009","unstructured":"Crews L, Patrick C, Achim CL et al (2009) Molecular pathology of neuro-AIDS (CNS-HIV). Int J Mol Sci 10:1045\u201363. doi: 10.3390\/ijms10031045","journal-title":"Int J Mol Sci"},{"key":"9546_CR27","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/13550280600760677","volume":"12","author":"A Daily","year":"2006","unstructured":"Daily A, Nath A, Hersh LB (2006) Tat peptides inhibit neprilysin. J Neurovirol 12:153\u201360. doi: 10.1080\/13550280600760677","journal-title":"J Neurovirol"},{"key":"9546_CR28","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3389\/fnagi.2013.00055","volume":"5","author":"BC Dickerson","year":"2013","unstructured":"Dickerson BC, Wolk DA (2013) Biomarker-based prediction of progression in MCI: Comparison of AD signature and hippocampal volume with spinal fluid amyloid-\u03b2 and tau. Front Aging Neurosci 5:55. doi: 10.3389\/fnagi.2013.00055","journal-title":"Front Aging Neurosci"},{"key":"9546_CR29","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1001\/archneur.59.6.923","volume":"59","author":"RJ Ellis","year":"2002","unstructured":"Ellis RJ, Moore DJ, Childers ME et al (2002) Progression to neuropsychological impairment in human immunodeficiency virus infection predicted by elevated cerebrospinal fluid levels of human immunodeficiency virus RNA. Arch Neurol 59:923\u20138","journal-title":"Arch Neurol"},{"key":"9546_CR30","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1093\/brain\/awl178","volume":"129","author":"H Engler","year":"2006","unstructured":"Engler H, Forsberg A, Almkvist O et al (2006) Two-year follow-up of amyloid deposition in patients with Alzheimer\u2019s disease. Brain 129:2856\u201366. doi: 10.1093\/brain\/awl178","journal-title":"Brain"},{"key":"9546_CR31","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/ana.20730","volume":"59","author":"AM Fagan","year":"2006","unstructured":"Fagan AM, Mintun MA, Mach RH et al (2006) Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans. Ann Neurol 59:512\u20139. doi: 10.1002\/ana.20730","journal-title":"Ann Neurol"},{"key":"9546_CR32","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1001\/archneurol.2011.105","volume":"68","author":"AM Fagan","year":"2011","unstructured":"Fagan AM, Shaw LM, Xiong C et al (2011) Comparison of analytical platforms for cerebrospinal fluid measures of \u03b2-amyloid 1\u201342, total tau, and p-tau181 for identifying Alzheimer disease amyloid plaque pathology. Arch Neurol 68:1137\u201344. doi: 10.1001\/archneurol.2011.105","journal-title":"Arch Neurol"},{"key":"9546_CR33","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/01.aids.0000432467.54003.f7","volume":"28","author":"LJ Garvey","year":"2014","unstructured":"Garvey LJ, Pavese N, Politis M et al (2014) Increased microglia activation in neurologically asymptomatic HIV-infected patients receiving effective ART. AIDS 28:67\u201372. doi: 10.1097\/01.aids.0000432467.54003.f7","journal-title":"AIDS"},{"key":"9546_CR34","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1080\/13550280490279816","volume":"10","author":"BB Gelman","year":"2004","unstructured":"Gelman BB, Schuenke K (2004) Brain aging in acquired immunodeficiency syndrome: increased ubiquitin-protein conjugate is correlated with decreased synaptic protein but not amyloid plaque accumulation. J Neurovirol 10:98\u2013108. doi: 10.1080\/13550280490279816","journal-title":"J Neurovirol"},{"key":"9546_CR35","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1471-2377-9-63","volume":"9","author":"M Gissl\u00e9n","year":"2009","unstructured":"Gissl\u00e9n M, Krut J, Andreasson U et al (2009) Amyloid and tau cerebrospinal fluid biomarkers in HIV infection. BMC Neurol 9:63. doi: 10.1186\/1471-2377-9-63","journal-title":"BMC Neurol"},{"key":"9546_CR36","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s10495-009-0314-1","volume":"14","author":"M-L Gougeon","year":"2009","unstructured":"Gougeon M-L, Piacentini M (2009) New insights on the role of apoptosis and autophagy in HIV pathogenesis. Apoptosis 14:501\u20138. doi: 10.1007\/s10495-009-0314-1","journal-title":"Apoptosis"},{"key":"9546_CR37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1750-3639.1996.tb00775.x","volume":"6","author":"F Gray","year":"1996","unstructured":"Gray F, Scaravilli F, Everall I, Chretien F (1996) Neuropathology of Early HIV\u20101 Infection. Brain Pathol 6:1\u201312","journal-title":"Brain Pathol"},{"key":"9546_CR38","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/01.aids.0000161770.06158.5c","volume":"19","author":"DA Green","year":"2005","unstructured":"Green DA, Masliah E, Vinters HV et al (2005) Brain deposition of beta-amyloid is a common pathologic feature in HIV positive patients. AIDS 19:407\u201311","journal-title":"AIDS"},{"key":"9546_CR39","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1742-6405-7-15","volume":"7","author":"L Hagberg","year":"2010","unstructured":"Hagberg L, Cinque P, Gisslen M et al (2010) Cerebrospinal fluid neopterin: an informative biomarker of central nervous system immune activation in HIV-1 infection. AIDS Res Ther 7:15. doi: 10.1186\/1742-6405-7-15","journal-title":"AIDS Res Ther"},{"key":"9546_CR40","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","volume":"256","author":"JA Hardy","year":"1992","unstructured":"Hardy JA, Higgins GA (1992) Alzheimer\u2019s disease: the amyloid cascade hypothesis. Science 256:184\u20135","journal-title":"Science"},{"key":"9546_CR41","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.bbalip.2010.05.003","volume":"1801","author":"NJ Haughey","year":"2010","unstructured":"Haughey NJ, Bandaru VVR, Bae M, Mattson MP (2010) Roles for dysfunctional sphingolipid metabolism in Alzheimer\u2019s disease neuropathogenesis. Biochim Biophys Acta 1801:878\u201386. doi: 10.1016\/j.bbalip.2010.05.003","journal-title":"Biochim Biophys Acta"},{"key":"9546_CR42","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1007\/s11481-013-9506-0","volume":"8","author":"NJ Haughey","year":"2013","unstructured":"Haughey NJ, Zhu X, Bandaru VVR (2013) A biological perspective of CSF lipids as surrogate markers for cognitive status in HIV. J Neuroimmune Pharmacol 8:1136\u201346. doi: 10.1007\/s11481-013-9506-0","journal-title":"J Neuroimmune Pharmacol"},{"key":"9546_CR43","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1212\/WNL.0b013e318200d727","volume":"75","author":"RK Heaton","year":"2010","unstructured":"Heaton RK, Clifford DB, Franklin DR et al (2010) HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology 75:2087\u201396. doi: 10.1212\/WNL.0b013e318200d727","journal-title":"Neurology"},{"key":"9546_CR44","doi-asserted-by":"crossref","first-page":"8354","DOI":"10.1523\/JNEUROSCI.0616-08.2008","volume":"28","author":"SE Hickman","year":"2008","unstructured":"Hickman SE, Allison EK, El Khoury J (2008) Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer\u2019s disease mice. J Neurosci 28:8354\u201360. doi: 10.1523\/JNEUROSCI.0616-08.2008","journal-title":"J Neurosci"},{"key":"9546_CR45","doi-asserted-by":"crossref","first-page":"e66381","DOI":"10.1371\/journal.pone.0066381","volume":"8","author":"M H\u00f6ltt\u00e4","year":"2013","unstructured":"H\u00f6ltt\u00e4 M, Hansson O, Andreasson U et al (2013) Evaluating amyloid-\u03b2 oligomers in cerebrospinal fluid as a biomarker for Alzheimer\u2019s disease. PLoS One 8:e66381. doi: 10.1371\/journal.pone.0066381","journal-title":"PLoS One"},{"issue":"Suppl 1","key":"9546_CR46","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.neurobiolaging.2011.09.003","volume":"32","author":"DM Holtzman","year":"2011","unstructured":"Holtzman DM (2011) CSF biomarkers for Alzheimer\u2019s disease: current utility and potential future use. Neurobiol Aging 32(Suppl 1):S4\u20139. doi: 10.1016\/j.neurobiolaging.2011.09.003","journal-title":"Neurobiol Aging"},{"key":"9546_CR47","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1093\/brain\/awq277","volume":"133","author":"CR Jack","year":"2010","unstructured":"Jack CR, Wiste HJ, Vemuri P et al (2010) Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer\u2019s disease. Brain 133:3336\u201348. doi: 10.1093\/brain\/awq277","journal-title":"Brain"},{"key":"9546_CR48","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1038\/35073667","volume":"410","author":"M Kaul","year":"2001","unstructured":"Kaul M, Garden GA, Lipton SA (2001) Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 410:988\u2013994","journal-title":"Nature"},{"key":"9546_CR49","doi-asserted-by":"crossref","first-page":"e77972","DOI":"10.1371\/journal.pone.0077972","volume":"8","author":"J Kim","year":"2013","unstructured":"Kim J, Yoon J-H, Kim Y-S (2013a) HIV-1 Tat Interacts with and Regulates the Localization and Processing of Amyloid Precursor Protein. PLoS One 8:e77972. doi: 10.1371\/journal.pone.0077972","journal-title":"PLoS One"},{"key":"9546_CR50","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.bbrc.2013.08.047","volume":"439","author":"S-J Kim","year":"2013","unstructured":"Kim S-J, Ahn J-W, Kim H et al (2013b) Two \u03b2-strands of RAGE participate in the recognition and transport of amyloid-\u03b2 peptide across the blood brain barrier. Biochem Biophys Res Commun 439:252\u20137. doi: 10.1016\/j.bbrc.2013.08.047","journal-title":"Biochem Biophys Res Commun"},{"key":"9546_CR51","unstructured":"Klunk WE, Engler H, Nordberg A, et al. (2004) Imaging Brain Amyloid in Alzheimer\u2019 s Disease with Pittsburgh Compound-B. 306\u2013319."},{"key":"9546_CR52","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1001\/jamaneurol.2013.182","volume":"70","author":"DS Knopman","year":"2013","unstructured":"Knopman DS, Jack CR, Wiste HJ et al (2013) Selective Worsening of Brain Injury Biomarker Abnormalities in Cognitively Normal Elderly Persons With \u03b2-Amyloidosis. JAMA Neurol 70:1030\u20138. doi: 10.1001\/jamaneurol.2013.182","journal-title":"JAMA Neurol"},{"key":"9546_CR53","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1007\/s00415-012-6688-y","volume":"260","author":"JJ Krut","year":"2013","unstructured":"Krut JJ, Zetterberg H, Blennow K et al (2013) Cerebrospinal fluid Alzheimer\u2019s biomarker profiles in CNS infections. J Neurol 260:620\u20136. doi: 10.1007\/s00415-012-6688-y","journal-title":"J Neurol"},{"key":"9546_CR54","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nrn2168","volume":"8","author":"FM LaFerla","year":"2007","unstructured":"LaFerla FM, Green KN, Oddo S (2007) Intracellular amyloid-beta in Alzheimer\u2019s disease. Nat Rev Neurosci 8:499\u2013509. doi: 10.1038\/nrn2168","journal-title":"Nat Rev Neurosci"},{"key":"9546_CR55","doi-asserted-by":"crossref","first-page":"6925","DOI":"10.4049\/jimmunol.1100211","volume":"186","author":"X Lan","year":"2011","unstructured":"Lan X, Xu J, Kiyota T et al (2011) HIV-1 reduces Abeta-degrading enzymatic activities in primary human mononuclear phagocytes. J Immunol 186:6925\u201332. doi: 10.4049\/jimmunol.1100211","journal-title":"J Immunol"},{"key":"9546_CR56","doi-asserted-by":"crossref","unstructured":"Le Bastard N, Coart E, Vanderstichele H et al (2013) Comparison of two analytical platforms for the clinical qualification of Alzheimer\u2019s disease biomarkers in pathologically-confirmed dementia. J Alzheimer\u2019s Dis 33:117\u201331. doi: 10.3233\/JAD-2012-121246","DOI":"10.3233\/JAD-2012-121246"},{"key":"9546_CR57","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/mp.2008.84","volume":"15","author":"P Lewczuk","year":"2010","unstructured":"Lewczuk P, Kamrowski-Kruck H, Peters O et al (2010) Soluble amyloid precursor proteins in the cerebrospinal fluid as novel potential biomarkers of Alzheimer\u2019s disease: a multicenter study. Mol Psychiatry 15:138\u201345. doi: 10.1038\/mp.2008.84","journal-title":"Mol Psychiatry"},{"key":"9546_CR58","doi-asserted-by":"crossref","unstructured":"Liu Y, Jones M, Hingtgen CM et al (2000) Uptake of HIV-1 tat protein mediated by low-density lipoprotein receptor-related protein disrupts the neuronal metabolic balance of the receptor ligands. Nat Med 6:1380\u20137. doi: 10.1038\/82199","DOI":"10.1038\/82199"},{"key":"9546_CR59","first-page":"1959","volume":"46","author":"BJ Lopresti","year":"2005","unstructured":"Lopresti BJ, Klunk WE, Mathis CA (2005) Simplified quantification of Pittsburgh Compound B amyloid imaging PET studies: a comparative analysis. J Nucl Med 46:1959\u201372","journal-title":"J Nucl Med"},{"key":"9546_CR60","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/imm.12156","volume":"141","author":"MA Lynch","year":"2014","unstructured":"Lynch MA (2014) The impact of neuroimmune changes on development of amyloid pathology; relevance to Alzheimer\u2019s disease. Immunology 141:292\u2013301. doi: 10.1111\/imm.12156","journal-title":"Immunology"},{"key":"9546_CR61","first-page":"1871","volume":"1878","author":"R Madani","year":"2006","unstructured":"Madani R, Poirier R, Wolfer DP et al (2006) Lack of Neprilysin Suffices To Generate Murine Amyloid-Like Deposits in the Brain and Behavioral Deficit In Vivo 1878:1871\u20131878. doi: 10.1002\/jnr","journal-title":"Lack of Neprilysin Suffices To Generate Murine Amyloid-Like Deposits in the Brain and Behavioral Deficit In Vivo."},{"key":"9546_CR62","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/jnen\/61.1.85","volume":"61","author":"JL Mankowski","year":"2002","unstructured":"Mankowski JL, Queen SE, Tarwater PM et al (2002) Accumulation of beta-amyloid precursor protein in axons correlates with CNS expression of SIV gp41. J Neuropathol Exp Neurol 61:85\u201390","journal-title":"J Neuropathol Exp Neurol"},{"key":"9546_CR63","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1001\/2013.jamaneurol.405","volume":"70","author":"NL Marchant","year":"2013","unstructured":"Marchant NL, Reed BR, Sanossian N et al (2013) The aging brain and cognition: contribution of vascular injury and a\u03b2 to mild cognitive dysfunction. JAMA Neurol 70:488\u201395. doi: 10.1001\/2013.jamaneurol.405","journal-title":"JAMA Neurol"},{"key":"9546_CR64","doi-asserted-by":"crossref","first-page":"38601","DOI":"10.1074\/jbc.M304379200","volume":"278","author":"S Matsuda","year":"2003","unstructured":"Matsuda S, Matsuda Y, D\u2019Adamio L (2003) Amyloid beta protein precursor (AbetaPP), but not AbetaPP-like protein 2, is bridged to the kinesin light chain by the scaffold protein JNK-interacting protein 1. J Biol Chem 278:38601\u20136. doi: 10.1074\/jbc.M304379200","journal-title":"J Biol Chem"},{"key":"9546_CR65","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/sj.cdd.4401577","volume":"1","author":"MP Mattson","year":"2005","unstructured":"Mattson MP, Haughey NJ, Nath A (2005) Cell death in HIV dementia. Cell Death Differ 1:893\u2013904. doi: 10.1038\/sj.cdd.4401577","journal-title":"Cell Death Differ"},{"key":"9546_CR66","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.jalz.2011.05.2243","volume":"Alzheimers Deme","author":"N Mattsson","year":"2011","unstructured":"Mattsson N, Andreasson U, Persson S (2011) The Alzheimer\u2019s Association external quality control program for cerebrospinal fluid biomarkers. Alzheimers Dement Alzheimers Dement 7:386\u2013395. doi: 10.1016\/j.jalz.2011.05.2243","journal-title":"Alzheimers Dement"},{"key":"9546_CR67","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1001\/jama.2009.1064","volume":"302","author":"N Mattsson","year":"2009","unstructured":"Mattsson N, Zetterberg H, Hansson O et al (2009) CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. JAMA 302:385\u201393. doi: 10.1001\/jama.2009.1064","journal-title":"JAMA"},{"key":"9546_CR68","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1126\/science.1197623","volume":"330","author":"KG Mawuenyega","year":"2010","unstructured":"Mawuenyega KG, Sigurdson W, Ovod V et al (2010) Decreased clearance of CNS beta-amyloid in Alzheimer\u2019s disease. Science 330:1774. doi: 10.1126\/science.1197623","journal-title":"Science"},{"key":"9546_CR69","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1212\/01.wnl.0000228230.26044.a4","volume":"67","author":"MA Mintun","year":"2006","unstructured":"Mintun MA, Larossa GN, Sheline YI et al (2006) [11C] PIB in a nondemented population: potential antecedent marker of Alzheimer disease. Neurology 67:446\u201352. doi: 10.1212\/01.wnl.0000228230.26044.a4","journal-title":"Neurology"},{"key":"9546_CR70","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1385\/JMN:17:2:101","volume":"17","author":"JC Morris","year":"2001","unstructured":"Morris JC, Price JL (2001) Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer\u2019s disease. J Mol Neurosci 17:101\u201318","journal-title":"J Mol Neurosci"},{"key":"9546_CR71","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/ana.21843","volume":"67","author":"JC Morris","year":"2010","unstructured":"Morris JC, Roe CM, Xiong C et al (2010) APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging. Ann Neurol 67:122\u201331. doi: 10.1002\/ana.21843","journal-title":"Ann Neurol"},{"key":"9546_CR72","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/00002030-200103300-00005","volume":"15","author":"M Nebuloni","year":"2001","unstructured":"Nebuloni M, Pellegrinelli A, Ferri A et al (2001) Beta amyloid precursor protein and patterns of HIV p24 immunohistochemistry in different brain areas of AIDS patients. AIDS 15:571\u20135","journal-title":"AIDS"},{"key":"9546_CR73","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0014-4886(03)00027-X","volume":"183","author":"A Olsson","year":"2003","unstructured":"Olsson A, H\u00f6glund K, Sj\u00f6gren M et al (2003) Measurement of \u03b1- and \u03b2-secretase cleaved amyloid precursor protein in cerebrospinal fluid from Alzheimer patients. Exp Neurol 183:74\u201380. doi: 10.1016\/S0014-4886(03)00027-X","journal-title":"Exp Neurol"},{"key":"9546_CR74","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1093\/infdis\/jit088","volume":"207","author":"MJ Peluso","year":"2013","unstructured":"Peluso MJ, Meyerhoff DJ, Price RW et al (2013) Cerebrospinal fluid and neuroimaging biomarker abnormalities suggest early neurological injury in a subset of individuals during primary HIV infection. J Infect Dis 207:1703\u201312. doi: 10.1093\/infdis\/jit088","journal-title":"J Infect Dis"},{"key":"9546_CR75","doi-asserted-by":"crossref","unstructured":"Potter R, Patterson BW, Elbert DL, et al. (2013) Increased in vivo amyloid-\u03b242 production, exchange, and loss in presenilin mutation carriers. Sci Transl Med 5:189ra77. doi: 10.1126\/scitranslmed.3005615","DOI":"10.1126\/scitranslmed.3005615"},{"key":"9546_CR76","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s11481-013-9491-3","volume":"8","author":"RW Price","year":"2013","unstructured":"Price RW, Peterson J, Fuchs D et al (2013) Approach to Cerebrospinal Fluid (CSF) Biomarker Discovery and Evaluation in HIV Infection. J Neuroimmune Pharmacol 8:1147\u201358. doi: 10.1007\/s11481-013-9491-3","journal-title":"J Neuroimmune Pharmacol"},{"key":"9546_CR77","doi-asserted-by":"crossref","first-page":"10165","DOI":"10.1523\/JNEUROSCI.1146-13.2013","volume":"33","author":"JM Ramaker","year":"2013","unstructured":"Ramaker JM, Swanson TL, Copenhaver PF (2013) Amyloid precursor proteins interact with the heterotrimeric G protein Go in the control of neuronal migration. J Neurosci 33:10165\u201381. doi: 10.1523\/JNEUROSCI.1146-13.2013","journal-title":"J Neurosci"},{"key":"9546_CR78","doi-asserted-by":"crossref","first-page":"6820","DOI":"10.1073\/pnas.0900345106","volume":"106","author":"EM Reiman","year":"2009","unstructured":"Reiman EM, Chen K, Liu X et al (2009) Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer\u2019s disease. Proc Natl Acad Sci U S A 106:6820\u20135. doi: 10.1073\/pnas.0900345106","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9546_CR79","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S1474-4422(12)70228-4","volume":"11","author":"EM Reiman","year":"2012","unstructured":"Reiman EM, Quiroz YT, Fleisher AS et al (2012) Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer\u2019s disease in the presenilin 1 E280A kindred: a case\u2013control study. Lancet Neurol 11:1048\u20131056. doi: 10.1016\/S1474-4422(12)70228-4","journal-title":"Lancet Neurol"},{"key":"9546_CR80","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/00002030-200501280-00004","volume":"19","author":"HC Rempel","year":"2005","unstructured":"Rempel HC, Pulliam L (2005) HIV-1 Tat inhibits neprilysin and elevates amyloid beta. AIDS 19:127\u201335","journal-title":"AIDS"},{"key":"9546_CR81","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/s13365-012-0120-3","volume":"18","author":"K Robertson","year":"2012","unstructured":"Robertson K, Liner J, Meeker RB (2012) Antiretroviral neurotoxicity. J Neurovirol 18:388\u201399. doi: 10.1007\/s13365-012-0120-3","journal-title":"J Neurovirol"},{"key":"9546_CR82","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1212\/WNL.0b013e3181d9ed09","volume":"74","author":"KR Robertson","year":"2010","unstructured":"Robertson KR, Su Z, Margolis DM et al (2010) Neurocognitive effects of treatment interruption in stable HIV-positive patients in an observational cohort. Neurology 74:1260\u20136. doi: 10.1212\/WNL.0b013e3181d9ed09","journal-title":"Neurology"},{"key":"9546_CR83","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1212\/WNL.0b013e3182918ca6","volume":"80","author":"CM Roe","year":"2013","unstructured":"Roe CM, Fagan AM, Grant EA et al (2013) Amyloid imaging and CSF biomarkers in predicting cognitive impairment up to 7.5\u00a0years later. Neurology 80:1784\u201391. doi: 10.1212\/WNL.0b013e3182918ca6","journal-title":"Neurology"},{"key":"9546_CR84","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1001\/archneur.65.11.1467","volume":"65","author":"CM Roe","year":"2008","unstructured":"Roe CM, Mintun MA, D\u2019Angelo G et al (2008) Alzheimer disease and cognitive reserve: variation of education effect with carbon 11-labeled Pittsburgh Compound B uptake. Arch Neurol 65:1467\u201371. doi: 10.1001\/archneur.65.11.1467","journal-title":"Arch Neurol"},{"key":"9546_CR85","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1750-1326-8-20","volume":"8","author":"C Ros\u00e9n","year":"2013","unstructured":"Ros\u00e9n C, Hansson O, Blennow K, Zetterberg H (2013) Fluid biomarkers in Alzheimer\u2019s disease - current concepts. Mol Neurodegener 8:20. doi: 10.1186\/1750-1326-8-20","journal-title":"Mol Neurodegener"},{"key":"9546_CR86","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/ene.12006","volume":"20","author":"F Steinbrink","year":"2013","unstructured":"Steinbrink F, Evers S, Buerke B et al (2013) Cognitive impairment in HIV infection is associated with MRI and CSF pattern of neurodegeneration. Eur J Neurol 20:420\u20138. doi: 10.1111\/ene.12006","journal-title":"Eur J Neurol"},{"key":"9546_CR87","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.brainres.2011.05.015","volume":"1399","author":"M Strazza","year":"2011","unstructured":"Strazza M, Pirrone V, Wigdahl B, Nonnemacher MR (2011) Breaking down the barrier: the effects of HIV-1 on the blood\u2013brain barrier. Brain Res 1399:96\u2013115. doi: 10.1016\/j.brainres.2011.05.015","journal-title":"Brain Res"},{"key":"9546_CR88","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3109\/13550289809114528","volume":"4","author":"LI Strelow","year":"1998","unstructured":"Strelow LI, Watry DD, Fox HS, Nelson JA (1998) Efficient infection of brain microvascular endothelial cells by an in vivo-selected neuroinvasive SIVmac variant. J Neurovirol 4:269\u201380","journal-title":"J Neurovirol"},{"key":"9546_CR89","doi-asserted-by":"crossref","first-page":"e73377","DOI":"10.1371\/journal.pone.0073377","volume":"8","author":"Y Su","year":"2013","unstructured":"Su Y, D\u2019Angelo GM, Vlassenko AG et al (2013) Quantitative Analysis of PiB-PET with FreeSurfer ROIs. PLoS One 8:e73377. doi: 10.1371\/journal.pone.0073377","journal-title":"PLoS One"},{"issue":"Suppl 1","key":"9546_CR90","first-page":"S185","volume":"33","author":"K Ubhi","year":"2013","unstructured":"Ubhi K, Masliah E (2013) Alzheimer\u2019s disease: recent advances and future perspectives. J Alzheimers Dis 33(Suppl 1):S185\u201394. doi: 10.3233\/JAD-2012-129028","journal-title":"J Alzheimers Dis"},{"key":"9546_CR91","first-page":"119","volume":"21","author":"VG Valcour","year":"2013","unstructured":"Valcour VG (2013) HIV, aging, and cognition: emerging issues. Top Antivir Med 21:119\u201323","journal-title":"Top Antivir Med"},{"key":"9546_CR92","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jneuroim.2004.08.035","volume":"157","author":"A Vehmas","year":"2004","unstructured":"Vehmas A, Lieu J, Pardo CA (2004) Amyloid precursor protein expression in circulating monocytes and brain macrophages from patients with HIV-associated cognitive impairment. J Neuroimmunol 157:99\u2013110. doi: 10.1016\/j.jneuroim.2004.08.035","journal-title":"J Neuroimmunol"},{"key":"9546_CR93","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.nbd.2004.12.013","volume":"18","author":"JA White","year":"2005","unstructured":"White JA, Manelli AM, Holmberg KH et al (2005) Differential effects of oligomeric and fibrillar amyloid-beta 1\u201342 on astrocyte-mediated inflammation. Neurobiol Dis 18:459\u201365. doi: 10.1016\/j.nbd.2004.12.013","journal-title":"Neurobiol Dis"},{"key":"9546_CR94","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/s11481-008-9136-0","volume":"4","author":"J Xu","year":"2009","unstructured":"Xu J, Ikezu T (2009) The comorbidity of HIV-associated neurocognitive disorders and Alzheimer\u2019s disease: a foreseeable medical challenge in post-HAART era. J Neuroimmune Pharmacol 4:200\u201312. doi: 10.1007\/s11481-008-9136-0","journal-title":"J Neuroimmune Pharmacol"},{"key":"9546_CR95","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/2047-9158-1-19","volume":"1","author":"L Zheng","year":"2012","unstructured":"Zheng L, Cedazo-Minguez A, Hallbeck M et al (2012) Intracellular distribution of amyloid beta peptide and its relationship to the lysosomal system. Transl Neurodegener 1:19. doi: 10.1186\/2047-9158-1-19","journal-title":"Transl Neurodegener"}],"container-title":["Journal of Neuroimmune Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11481-014-9546-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11481-014-9546-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11481-014-9546-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,10]],"date-time":"2019-08-10T05:23:55Z","timestamp":1565414635000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11481-014-9546-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,10]]},"references-count":95,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["9546"],"URL":"https:\/\/doi.org\/10.1007\/s11481-014-9546-0","relation":{},"ISSN":["1557-1890","1557-1904"],"issn-type":[{"value":"1557-1890","type":"print"},{"value":"1557-1904","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,10]]}}}